Orbea variegata (L.) Haw in skin carcinogenesis: insights from an in vivo male Swiss mouse model study.
Oumaima ChgariHicham WahnouMartin NdayambajeFatimazahra MoukhfiOuafae BenkhnigueFarida MarnissiYouness LimamiMounia OudghiriPublished in: Journal of toxicology and environmental health. Part A (2024)
Skin cancer is the most widespread type of malignant tumor representing a major public health concern. Considering the numerous side effects associated with conventional treatments, phytotherapy may be regarded as a viable medicinal alternative. This study aimed to investigate the therapeutic potential of Orbea variegata (L.) Haw, an ornamental plant, in treating skin cancer using an animal model induced by a combination of ultraviolet (UV) irradiation and sulfuric acid treatment. The hydroethanolic extract of Orbea variegata underwent phytochemical characterization, identifying the presence of reducing sugars, coumarins, alkaloids, flavonoids, tannins, and saponins through qualitative screening. Quantitative analysis demonstrated significant amounts of phenolic compounds (29.435 ± 0.571 mg GAE/g of dry extract), flavonoids (6.711 ± 0.272 mg QE/g of dry extract), and tannins (274.037 ± 11.3 mg CE/g of dry extract). The administration the hydroethanolic extract in two concentrations (1 or 2 g/kg) to male Swiss mice exhibited no marked adverse effects, as evidenced by serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) enzyme activity levels. In addition, the extract significantly reduced skin hyperplasia and inflammation induced by UV/sulfuric acid treatment as noted in tissue analyses and decreased protein expression of nuclear proliferation marker (Ki-67). This improvement was associated with a marked decrease in oxidative stress, as indicated by diminished lipid peroxidation levels, and restoration of the activity of endogenous antioxidant enzyme catalase (CAT) to control levels. Our findings demonstrated the potential of Orbea variegata hydroethanolic extract to be considered as a treatment for skin cancer, exhibiting its apparent safety and efficacy in reducing inflammation and carcinogenesis in a UV/sulfuric acid-induced Swiss mouse model, attributed to its phytochemical content and associated antioxidant activities.
Keyphrases
- oxidative stress
- skin cancer
- anti inflammatory
- mouse model
- diabetic rats
- public health
- dna damage
- ischemia reperfusion injury
- induced apoptosis
- magnetic resonance imaging
- squamous cell carcinoma
- risk assessment
- heat shock
- magnetic resonance
- computed tomography
- radiation therapy
- combination therapy
- insulin resistance
- neoadjuvant chemotherapy
- lymph node
- wound healing
- quantum dots
- human health